Author

mbaum

  • Behavioral Economics

    #BELHP2014 Panel 2, Potential Problems and Limits of Nudges in Health Care

    [Ed. Note: On Friday, May 2 and Saturday, May 3, 2014, the Petrie-Flom Center hosted its 2014 annual conference: “Behavioral Economics, Law, and Health Policy.”  This is an installment in our series of live blog posts from the event;…

    #BELHP2014 Panel 2, Potential Problems and Limits of Nudges in Health Care

  • Bioethics

    The Neuroethics of Unintentional Memory-Modification

    By Matthew L Baum At least since the publication of the President’s Commission on Bioethics’ report in 2003, “Beyond Therapy: Biotechnology and the Pursuit of Happiness”, there has been an ongoing debate about the ethics of…

    The Neuroethics of Unintentional Memory-Modification

  • FDA

    Generics, Bioequivalence, and Justice

    By Matthew L Baum I have written previously on this blog about morally modifying technologies (here and here), which by definition work no better than existing technologies but enable the side-stepping of a moral tension associated…

    Generics, Bioequivalence, and Justice

  • Bioethics

    Biomarker Epistemology, Cognitive Decline, and Alzheimer’s Disease

    By Matthew L Baum This past Sunday, a group of researchers reported in the journal, Nature Medicine, a preliminary technique that uses variation in blood levels of 10 fats to predict the likelihood that elderly…

    Biomarker Epistemology, Cognitive Decline, and Alzheimer’s Disease

  • Bioethics

    Limits of Technological Solutions to Moral Problems

    By Matthew L Baum In my last blog post, I suggested that we consider incentivizing scientists and engineers to develop technologies that side-step ethical dilemmas entangling certain current technologies. I highlighted that these morally modifying…

    Limits of Technological Solutions to Moral Problems

  • Bioethics

    Technological Solutions to Moral Problems

    By Matthew L Baum When we consider our society’s tough moral questions, like whether it is acceptable to use embryonic stem cells for research and medicine, we often look towards governmental leaders, policy makers, lawyers,…

    Technological Solutions to Moral Problems

  • Global Health

    Infrastructure as a Social Determinant of Health in Developing Economies

    By Matthew L Baum Recently in the New England Journal of Medicine, D.S. Jones described the history of a dangerous new technology, the detrimental health effects of which had clinicians very worried. That technology was the…

    Infrastructure as a Social Determinant of Health in Developing Economies

  • Conflicts of Interest

    Conflicts of Interests and the Goals of Translational Medicine

    By Matthew L Baum There are many ways to drive medicine forward. One is to work to remove economic, political, or geographic barriers to accessing care, and thus aid those whose suffering can be assuaged…

    Conflicts of Interests and the Goals of Translational Medicine

  • Bioethics

    Educating ELSI

    By Matthew L Baum “Examining the intersection of law and health care, biotech & bioethics” – the subtitle of the Bill of Health blog. I approach this intersection like many of my fellow students: outfitted…

    Educating ELSI